pyrroles has been researched along with su 5614 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, E; Longley, BJ; Ma, Y; McMahon, G | 1 |
| Cherrington, JM; Knox, SJ; Laird, D; Ning, S | 1 |
| Cherrington, JM; Griffith, DJ; Heinrich, MC; McGreevey, LS; McMahon, G; O'Farrell, AM; Smolich, BD; Wait, CL; Yee, KW | 1 |
| Voutsadakis, IA | 1 |
| Augustin, HG; Hecker, M; Heiss, M; Hellström, M; Kalén, M; Korff, T; May, T; Weber, H | 1 |
2 review(s) available for pyrroles and su 5614
| Article | Year |
|---|---|
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors.
Topics: Amino Acid Substitution; Combined Modality Therapy; Drug Design; Enzyme Activation; Enzyme Inhibitors; Feasibility Studies; Humans; Indoles; Ligands; Mast Cells; Mastocytosis; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Proto-Oncogenes; Pyrroles; Stem Cell Factor | 2000 |
Flt3 in acute myelogenous leukemia: biology, prognosis, and therapeutic implications.
Topics: Adult; Animals; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Indoles; Leukemia, Myeloid, Acute; Mice; Middle Aged; Prognosis; Proto-Oncogene Proteins; Pyrroles; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Treatment Outcome | 2003 |
3 other study(ies) available for pyrroles and su 5614
| Article | Year |
|---|---|
The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Drug Screening Assays, Antitumor; Endothelial Growth Factors; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Indoles; Lymphokines; Mice; Mice, Inbred C3H; Neoplasm Proteins; Oxindoles; Platelet-Derived Growth Factor; Propionates; Pyrroles; Radiation-Sensitizing Agents; Radioisotope Teletherapy; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; RNA, Neoplasm; Specific Pathogen-Free Organisms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase.
Topics: Amino Acid Sequence; Apoptosis; Base Sequence; Cell Division; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Exons; fms-Like Tyrosine Kinase 3; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indoles; Molecular Sequence Data; Mutagenesis, Site-Directed; Polymerase Chain Reaction; Proto-Oncogene Proteins; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Cell Surface; Recombinant Proteins; Tumor Cells, Cultured | 2002 |
Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Cells, Cultured; Drug Evaluation, Preclinical; Endothelial Cells; Fibroblast Growth Factor 2; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Indoles; Microscopy, Video; Neovascularization, Physiologic; Pyrroles; Recombinant Proteins; Spheroids, Cellular; Vascular Endothelial Growth Factor A | 2015 |